Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

When does pathway inhibition count as astrocyte targeting in multiple sclerosis?

  • Zhufeng Chen
  • Ming Luo
Open at sourceDOICite

Related

  1. Targeting Mitochondrial Redox Signaling Promotes Neuroregeneration and Functional Recovery in a Multiple Sclerosis Model.
    Yuki Narushima, Joshua Saylor, Shun Saito +16
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textNeuroscienceEurope PMCPMC
  2. Breaking the link between demyelination and axon loss: SARM1 inhibition as a neuroprotective strategy for multiple sclerosis
    M. Feri, S. Peterson, M. Rezanejad +7
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  3. Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade.
    Sailish Honap, Michael Colwill, Axel Dignass +4
    EGastroenterologyPeer-reviewedCC BY-NCFull textGenetics & genomicsEurope PMCPMC
  4. Pathophysiology and imaging of early memory impairment in multiple sclerosis
    Thomas Tourdias
    GliaPeer-reviewedLicence not statedNeuroscienceHAL
  5. Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy
    Thomas Tourdias, Vincent Dousset
    NeurotherapeuticsPeer-reviewedLicence not statedFull text30 citedNeuroscienceHAL

Cite

BibTeXRIS
BibTeX
@article{chen2026when,
  title = {{When does pathway inhibition count as astrocyte targeting in multiple sclerosis?}},
  author = {Zhufeng Chen and Ming Luo},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = nov,
  doi = {10.3389/fimmu.2026.2018483},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2018483},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - When does pathway inhibition count as astrocyte targeting in multiple sclerosis?
AU  - Zhufeng Chen
AU  - Ming Luo
PY  - 2026
DA  - 2026/11/09
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.2018483
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2018483
SN  - 1664-3224
ER  -